These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 32700193)

  • 1. The Roles of Common Variation and Somatic Mutation in Cancer Pharmacogenomics.
    Chan HT; Chin YM; Low SK
    Oncol Ther; 2019 Jun; 7(1):1-32. PubMed ID: 32700193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast cancer: The translation of big genomic data to cancer precision medicine.
    Low SK; Zembutsu H; Nakamura Y
    Cancer Sci; 2018 Mar; 109(3):497-506. PubMed ID: 29215763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and Implementing Pharmacogenomics Study in Cancer.
    Romero Lagunes ML; Vera Badillo FE
    Adv Exp Med Biol; 2019; 1168():43-77. PubMed ID: 31713164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Next Generation Sequencing (NGS): A Revolutionary Technology in Pharmacogenomics and Personalized Medicine in Cancer.
    Morganti S; Tarantino P; Ferraro E; D'Amico P; Duso BA; Curigliano G
    Adv Exp Med Biol; 2019; 1168():9-30. PubMed ID: 31713162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Individualized network-based drug repositioning infrastructure for precision oncology in the panomics era.
    Cheng F; Hong H; Yang S; Wei Y
    Brief Bioinform; 2017 Jul; 18(4):682-697. PubMed ID: 27296652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomics-Enabled Precision Medicine for Cancer.
    Roos A; Byron SA
    Cancer Treat Res; 2019; 178():137-169. PubMed ID: 31209844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Next generation sequencing of vitreoretinal lymphomas from small-volume intraocular liquid biopsies: new routes to targeted therapies.
    Cani AK; Hovelson DH; Demirci H; Johnson MW; Tomlins SA; Rao RC
    Oncotarget; 2017 Jan; 8(5):7989-7998. PubMed ID: 28002793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modern developments in germline pharmacogenomics for oncology prescribing.
    Reizine NM; O'Donnell PH
    CA Cancer J Clin; 2022 Jul; 72(4):315-332. PubMed ID: 35302652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Data resources for the identification and interpretation of actionable mutations by clinicians.
    Prawira A; Pugh TJ; Stockley TL; Siu LL
    Ann Oncol; 2017 May; 28(5):946-957. PubMed ID: 28327901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacogenomics to Predict Tumor Therapy Response: A Focus on ATP-Binding Cassette Transporters and Cytochromes P450.
    Hlaváč V; Holý P; Souček P
    J Pers Med; 2020 Aug; 10(3):. PubMed ID: 32872162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Personalized genomic analyses for cancer mutation discovery and interpretation.
    Jones S; Anagnostou V; Lytle K; Parpart-Li S; Nesselbush M; Riley DR; Shukla M; Chesnick B; Kadan M; Papp E; Galens KG; Murphy D; Zhang T; Kann L; Sausen M; Angiuoli SV; Diaz LA; Velculescu VE
    Sci Transl Med; 2015 Apr; 7(283):283ra53. PubMed ID: 25877891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complexity of genome sequencing and reporting: Next generation sequencing (NGS) technologies and implementation of precision medicine in real life.
    Morganti S; Tarantino P; Ferraro E; D'Amico P; Viale G; Trapani D; Duso BA; Curigliano G
    Crit Rev Oncol Hematol; 2019 Jan; 133():171-182. PubMed ID: 30661654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Whole-Exome Sequencing of Metastatic Cancer and Biomarkers of Treatment Response.
    Beltran H; Eng K; Mosquera JM; Sigaras A; Romanel A; Rennert H; Kossai M; Pauli C; Faltas B; Fontugne J; Park K; Banfelder J; Prandi D; Madhukar N; Zhang T; Padilla J; Greco N; McNary TJ; Herrscher E; Wilkes D; MacDonald TY; Xue H; Vacic V; Emde AK; Oschwald D; Tan AY; Chen Z; Collins C; Gleave ME; Wang Y; Chakravarty D; Schiffman M; Kim R; Campagne F; Robinson BD; Nanus DM; Tagawa ST; Xiang JZ; Smogorzewska A; Demichelis F; Rickman DS; Sboner A; Elemento O; Rubin MA
    JAMA Oncol; 2015 Jul; 1(4):466-74. PubMed ID: 26181256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical pharmacogenomics testing in the era of next generation sequencing: challenges and opportunities for precision medicine.
    Ji Y; Si Y; McMillin GA; Lyon E
    Expert Rev Mol Diagn; 2018 May; 18(5):411-421. PubMed ID: 29634383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel molecular diagnostics platform for somatic and germline precision oncology.
    Cabanillas R; Diñeiro M; Castillo D; Pruneda PC; Penas C; Cifuentes GA; de Vicente Á; Durán NS; Álvarez R; Ordóñez GR; Cadiñanos J
    Mol Genet Genomic Med; 2017 Jul; 5(4):336-359. PubMed ID: 28717660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in computational approaches for prioritizing driver mutations and significantly mutated genes in cancer genomes.
    Cheng F; Zhao J; Zhao Z
    Brief Bioinform; 2016 Jul; 17(4):642-56. PubMed ID: 26307061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Next-generation sequencing-based clinical sequencing: toward precision medicine in solid tumors.
    Wakai T; Prasoon P; Hirose Y; Shimada Y; Ichikawa H; Nagahashi M
    Int J Clin Oncol; 2019 Feb; 24(2):115-122. PubMed ID: 30515675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Next generation sequencing in cancer: opportunities and challenges for precision cancer medicine.
    Paolillo C; Londin E; Fortina P
    Scand J Clin Lab Invest Suppl; 2016; 245():S84-91. PubMed ID: 27542004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cancer genome analysis through next-generation sequencing].
    Aburatani H
    Gan To Kagaku Ryoho; 2011 Jan; 38(1):1-6. PubMed ID: 21368453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A computational approach to distinguish somatic vs. germline origin of genomic alterations from deep sequencing of cancer specimens without a matched normal.
    Sun JX; He Y; Sanford E; Montesion M; Frampton GM; Vignot S; Soria JC; Ross JS; Miller VA; Stephens PJ; Lipson D; Yelensky R
    PLoS Comput Biol; 2018 Feb; 14(2):e1005965. PubMed ID: 29415044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.